Many kidney disease patients with atrial fibrillation are not treated with anticoagulation, increasing their risk of stroke.
Study finds different anticoagulation treatment levels for patients with cognitive problems.
A meta-analysis of 95 studies indicates lower risk of stroke and intracranial hemorrhage.
A massive retrospective study compared several non-vitamin K antagonist oral anticoagulants (NOACs) to warfarin.
Using oral anticoagulants and nonsteroidal anti-inflammatory drugs (NSAIDs) together increases the risk for major bleeding and stroke in patients with atrial fibrillation (AF), according to a new analysis.